Business Context and Reporting Period
New Horizon Aircraft Ltd. is a pre-revenue aerospace company developing the hybrid-electric Cavorite X7 eVTOL aircraft for regional, civilian and military applications. This Form 10-Q covers the fiscal third quarter and nine months ended February 29, 2024; comparative results are for the periods ended February 28, 2023. Financial statement amounts are in thousands of Canadian dollars, except per-share data.
The January 12, 2024 business combination with Robinson Aircraft Ltd. was accounted for as a reverse recapitalization. Results before closing principally reflect Legacy Horizon’s operations.
Financial Results and Position
| Metric | Three months ended Feb. 29, 2024 | Nine months ended Feb. 29, 2024 |
|---|---|---|
| Revenue | None | None |
| Research and development | $270 | $635 |
| General and administrative | $989 | $1,829 |
| Operating loss | ($1,259) | ($2,464) |
| Net loss | ($5,306) | ($6,463) |
| Basic and diluted loss per share | ($0.45) | ($0.80) |
- Revenue and operating margins are not meaningful because the company has not begun generating revenue.
- Nine-month operating cash use was $760, investing cash use was $158, and financing cash provided was $5,105. Cash increased by $4,187 to $4,415 at period-end.
- At February 29, current assets were $6,561, including cash of $4,415; current liabilities were $2,303. Total liabilities were $22,960, including a $20,622 Forward Purchase Agreement derivative liability. Shareholders’ deficit was $16,142.
- No term loan, promissory note or convertible debt remained outstanding at period-end; the convertible instruments had been repaid or converted. Operating lease liabilities totaled $88.
Material Changes Versus Prior Comparable Period
- Third-quarter operating expenses rose to $1,259 from $293, mainly due to increased professional fees, staffing and other growth-related administration. R&D rose to $270 from $138; G&A rose to $989 from $155.
- Nine-month operating expenses increased to $2,464 from $1,031. Net loss widened to $6,463 from $803, including a $4,026 non-cash expense from the change in fair value of the Forward Purchase Agreement.
- Operating cash use was broadly similar to the prior period ($760 versus $773). Financing cash flow increased, reflecting $6,700 of convertible-note proceeds received in October 2023, later converted into shares, partly offset by business-combination costs.
- Cash rose from $228 at May 31, 2023 to $4,415 at February 29, 2024. The company also reported substantial growth in accounts payable, accrued liabilities and prepaid expenses.
Outlook, Risks and Unusual Items
- Management expects existing cash and business-combination-related resources to fund the current operating plan for at least 12 months from the date the financial statements were available to be issued. The filing cautions that additional capital may be needed beyond that period and that funding may not be available on acceptable terms.
- Management anticipates commercialization beginning in 2027, but the aircraft remains in development and flight testing. The filing provides no numerical revenue or earnings guidance.
- Key risks include aircraft development and cost uncertainty, lengthy and costly certification, uncertain demand for the undeveloped regional air mobility market, competition, and the need for further financing. Certification may take more than five years and cost hundreds of millions of dollars, according to the filing.
- The Forward Purchase Agreement liability is a Level 3 fair-value estimate using model assumptions; changes in those assumptions could materially affect its valuation. The company recorded a $4,026 fair-value expense in the nine-month period.
- Disclosure controls and procedures were deemed ineffective at period-end because of a material weakness involving insufficient technical accounting resources and inadequate separation of financial responsibilities. Remediation was ongoing.
- The company reported no material legal proceedings, no off-balance-sheet arrangements, and no material changes to the risk factors in its referenced annual report.
Important Facts for Investors to Verify
- Confirm the expected timing, cost and financing plan for development, flight testing and certification, including the assumptions underlying the 2027 commercialization target.
- Review the Forward Purchase Agreement’s terms, potential cash and share settlement effects, and sensitivity of the $20,622 Level 3 liability to valuation assumptions.
- Reconcile transaction funding, redemptions, fees and cash available after the business combination; the filing describes significant redemptions and expenses.
- Track cash burn and whether management secures additional capital before its stated 12-month funding horizon expires.
- Monitor remediation and independent validation of the disclosed material weakness in financial reporting controls.
- Reconcile share counts: the balance sheet reports 17,995,436 shares outstanding at February 29, 2024, while the cover reports 18,220,436 as of April 22, 2024.